JPS57146713A - Hypoglycemic - Google Patents

Hypoglycemic

Info

Publication number
JPS57146713A
JPS57146713A JP3351381A JP3351381A JPS57146713A JP S57146713 A JPS57146713 A JP S57146713A JP 3351381 A JP3351381 A JP 3351381A JP 3351381 A JP3351381 A JP 3351381A JP S57146713 A JPS57146713 A JP S57146713A
Authority
JP
Japan
Prior art keywords
digestive
hypoglycemic
saccharides
active ingredients
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3351381A
Other languages
Japanese (ja)
Inventor
Akira Endo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP3351381A priority Critical patent/JPS57146713A/en
Publication of JPS57146713A publication Critical patent/JPS57146713A/en
Pending legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: A hypoglycemic that contains saccharides selected from hard-digestive polysaccharides, oligosaccharides and their derivatives as active ingredients, thus being used as preventive and remedy for metabolic diseases or digestive diseases.
CONSTITUTION: The objective hypoglycemic is obtained by using saccharides selected from hard-digestive polysaccharides, oligosaccharides and these derivatives as active ingredients. The resultant hypoglycemic is effective for metabolic diseases such as hyperglycemic, diabetes, corpulency or arteriosclerosis, caused by excessive intake of readily digestive saccharides, especially starch or sucrose, and for preventing and treating digestive diseases such as diarrhea caused by unbalanced diet by excessive intake of readily digestive saccharides, gastrointestinal catarrh or abnormal itestinal fermentation. It is given orally, intraperitoneally or intravenously, however, it is suitable for oral administration more and is low toxicity. The saccharide as the active ingredients is produced by a microorganism or by a plant or animal, or obtained as its derivative.
COPYRIGHT: (C)1982,JPO&Japio
JP3351381A 1981-03-09 1981-03-09 Hypoglycemic Pending JPS57146713A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3351381A JPS57146713A (en) 1981-03-09 1981-03-09 Hypoglycemic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3351381A JPS57146713A (en) 1981-03-09 1981-03-09 Hypoglycemic

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP58186304A Division JPS59112922A (en) 1983-10-05 1983-10-05 Agent for lowering blood sugar
JP58186305A Division JPS59113856A (en) 1983-10-05 1983-10-05 Saccharine food

Publications (1)

Publication Number Publication Date
JPS57146713A true JPS57146713A (en) 1982-09-10

Family

ID=12388621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3351381A Pending JPS57146713A (en) 1981-03-09 1981-03-09 Hypoglycemic

Country Status (1)

Country Link
JP (1) JPS57146713A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5974976A (en) * 1982-10-25 1984-04-27 Yasutake Hichi Drink and food containing suppressant against rise in value of blood sugar
JPS604131A (en) * 1983-06-21 1985-01-10 Showa Sangyo Kk Blood sugar lowering agent
DE3421954C1 (en) * 1984-06-13 1985-10-24 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Dietetic food containing hydroxyethyl starch
JPS62201821A (en) * 1986-02-28 1987-09-05 Nippon Shokuhin Kako Kk Substance for suppressing hyperglycemia
US4818751A (en) * 1985-07-02 1989-04-04 Zeria Shinyaku Kogyo Kabushiki Kaisha Cosmetics
WO1991004751A1 (en) * 1989-10-02 1991-04-18 Shigeo Ochi Inhibitor of absorption of digestion product of food and drink
JP2006327959A (en) * 2005-05-24 2006-12-07 Toshitsu Kagaku Kenkyusho:Kk Remedy for endocrine disease and metabolic disease
US7423027B2 (en) 2004-02-19 2008-09-09 Abbott Laboratories Methods of using gamma cyclodextrin to control blood glucose and insulin secretion

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52122342A (en) * 1976-04-02 1977-10-14 Bayer Ag Amino sugar derivatives
JPS52142018A (en) * 1976-03-31 1977-11-26 Magyar Tudomanyos Akademia Essential ion complex
JPS5323976A (en) * 1976-08-13 1978-03-06 Meiji Seika Kaisha Ltd Nojirimycin. glucose oligomer and its preparation
JPS5443599A (en) * 1977-09-13 1979-04-06 Murata Manufacturing Co Piezooelectric crystalline membrane of zinc oxide
JPS5492909A (en) * 1977-12-28 1979-07-23 Toyo Jozo Co Ltd New aminosaccharide and its preparation
JPS54163511A (en) * 1978-02-14 1979-12-26 Hoffmann La Roche Aminosugar derivative

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52142018A (en) * 1976-03-31 1977-11-26 Magyar Tudomanyos Akademia Essential ion complex
JPS52122342A (en) * 1976-04-02 1977-10-14 Bayer Ag Amino sugar derivatives
JPS5323976A (en) * 1976-08-13 1978-03-06 Meiji Seika Kaisha Ltd Nojirimycin. glucose oligomer and its preparation
JPS5443599A (en) * 1977-09-13 1979-04-06 Murata Manufacturing Co Piezooelectric crystalline membrane of zinc oxide
JPS5492909A (en) * 1977-12-28 1979-07-23 Toyo Jozo Co Ltd New aminosaccharide and its preparation
JPS54163511A (en) * 1978-02-14 1979-12-26 Hoffmann La Roche Aminosugar derivative

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5974976A (en) * 1982-10-25 1984-04-27 Yasutake Hichi Drink and food containing suppressant against rise in value of blood sugar
JPS6153029B2 (en) * 1982-10-25 1986-11-15 Yasutake Hichi
JPS604131A (en) * 1983-06-21 1985-01-10 Showa Sangyo Kk Blood sugar lowering agent
DE3421954C1 (en) * 1984-06-13 1985-10-24 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Dietetic food containing hydroxyethyl starch
US4818751A (en) * 1985-07-02 1989-04-04 Zeria Shinyaku Kogyo Kabushiki Kaisha Cosmetics
JPS62201821A (en) * 1986-02-28 1987-09-05 Nippon Shokuhin Kako Kk Substance for suppressing hyperglycemia
WO1991004751A1 (en) * 1989-10-02 1991-04-18 Shigeo Ochi Inhibitor of absorption of digestion product of food and drink
US5364636A (en) * 1989-10-02 1994-11-15 Hanabusa Patent Office Inhibitor of absorption of digestion product of food and drink
US7423027B2 (en) 2004-02-19 2008-09-09 Abbott Laboratories Methods of using gamma cyclodextrin to control blood glucose and insulin secretion
US8420621B2 (en) 2004-02-19 2013-04-16 Abbott Laboratories Methods of using gamma cyclodextrin to control blood glucose and insulin secretion
JP2006327959A (en) * 2005-05-24 2006-12-07 Toshitsu Kagaku Kenkyusho:Kk Remedy for endocrine disease and metabolic disease

Similar Documents

Publication Publication Date Title
DE69910559T2 (en) NEW FAT ANALOGS FOR THE TREATMENT OF OBESITY
Ravi et al. Anti-diabetic activity of Eugenia jambolana seed kernels on streptozotocin-induced diabetic rats
Capasso et al. Antipyretic and antibacterial actions of Teucrium polium (L.)
Satoh et al. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics
DE69533593T2 (en) PREPARATIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDER CONTAINING ARABINOGALACTAN AND POLYPHENOLS OF LARIX.
US5318986A (en) Method of inhibiting the activity of α-amylase
Satoh et al. Role of food in gastrointestinal ulceration produced by indomethacin in the rat
DE3500179A1 (en) ACETYLERYTHROMYCINSTEARATE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCT CONTAINING THIS
JPS57146713A (en) Hypoglycemic
Deeptha et al. Dose dependent inhibitory effect of dietary caraway on 1, 2-dimethylhydrazine induced colonic aberrant crypt foci and bacterial enzyme activity in rats
IE780098L (en) Safeguarded toxic chemical compositions containing an¹emetic
Yeşilada et al. Anti-ulcerogenic effects of Spartium junceum flowers on in vivo test models in rats
DE2921328C3 (en) Medicines for the treatment of hyperglycaemia, hyperlipemia, hypertension, inflammatory diseases, pain, pyrexia and tumors
US5464620A (en) Pharmaceutical composition for treating gastrointestinal disease
DE2206570A1 (en) Remedies for treating liver affections
US4328246A (en) Anti Walker 256 carcinoma agent and combination thereof
Fabia et al. Effect of pentoxifylline on hepatic ischemia and reperfusion injury
Salim Use of scavenging oxygen‐derived free radicals to protect the rat against aspirin‐and ethanol‐induced erosive gastritis
US6638523B1 (en) Method of treating ulcers
JPS5430146A (en) Novel anthracycline derivatives and their preparation
JPH08231396A (en) Anti-helicobacter pylori medicine
Gustafsson et al. Prolonged induction of germfree bile acid pattern in conventional rats by antibiotics
CH644018A5 (en) PHARMACEUTICAL AGENT FOR PROSTAGLAND REGULATION.
JPS55122715A (en) Antidiabetic agent
DE2759108A1 (en) USE OF ALPHA -MERCAPTO-BETA-ARYL-ACRYLIC ACIDS IN INCREASING THE ZINC CONTENT IN SERUM AND TISSUE